Messenger RNA therapy for rare genetic metabolic diseases

Gut
Pedro BerraondoAntonio Fontanellas

Abstract

Decades of intense research in molecular biology and biochemistry are fructifying in the emergence of therapeutic messenger RNAs (mRNA) as a new class of drugs. Synthetic mRNAs can be sequence optimised to improve translatability into proteins, as well as chemically modified to reduce immunogenicity and increase chemical stability using naturally occurring uridine modifications. These structural improvements, together with the development of safe and efficient vehicles that preserve mRNA integrity in circulation and allow targeted intracellular delivery, have paved the way for mRNA-based therapeutics. Indeed, mRNAs formulated into biodegradable lipid nanoparticles are currently being tested in preclinical and clinical studies for multiple diseases including cancer immunotherapy and vaccination for infectious diseases. An emerging application of mRNAs is the supplementation of proteins that are not expressed or are not functional in a regulated and tissue-specific manner. This so-called 'protein replacement therapy' could represent a solution for genetic metabolic diseases currently lacking effective treatments. Here we summarise this new class of drugs and discuss the preclinical evidence supporting the potential of liver-media...Continue Reading

References

Apr 14, 1983·The New England Journal of Medicine·S M MatsuiL E Rosenberg
Jun 22, 1999·Molecular and Cellular Biology·Z WangM Kiledjian
Oct 3, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D MoriokaA Nakagawa
Dec 22, 2007·Nature Reviews. Drug Discovery·Benjamin LeaderDavid E Golan
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
Sep 18, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katalin KarikóDrew Weissman
Apr 21, 2009·Molecular Genetics and Metabolism·M A CossonP de Lonlay
Dec 24, 2009·Transplant International : Official Journal of the European Society for Organ Transplantation·Staffan WahlinBo-Göran Ericzon
May 13, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Akin AkincMartin A Maier
Sep 30, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Carmen UnzuAntonio Fontanellas
Mar 10, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sharon C CunninghamIan E Alexander
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Dec 14, 2011·The New England Journal of Medicine·Amit C NathwaniAndrew M Davidoff
Jan 10, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J K DowmanP N Newsome
Oct 31, 2012·Journal of Inherited Metabolic Disease·Olivier BraissantCristina Cudalbu
Nov 2, 2012·Journal of Inherited Metabolic Disease·George ElderJean-Charles Deybach
Jan 18, 2013·Nucleic Acids Research·Paulo GasparJosé Luís Oliveira
Apr 13, 2013·Journal of Hepatology·Stefano FagiuoliGiuseppe Remuzzi
Sep 23, 2014·Nature Reviews. Drug Discovery·Ugur SahinÖzlem Türeci
Dec 3, 2014·The American Journal of Medicine·D Montgomery BissellPaul D Blanc
Mar 17, 2015·The Journal of Pediatrics·Anna-Kaisa NiemiGregory M Enns
Apr 16, 2015·Journal of Inherited Metabolic Disease·Stefan KölkerPeter Burgard
Apr 16, 2015·Journal of Inherited Metabolic Disease·Stefan KölkerAngeles Garcia Cazorla
May 11, 2015·Orphanet Journal of Rare Diseases·Anais BrassierPascale De Lonlay
May 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert H I AndtbackaRobert S Coffin
May 24, 2016·Journal of Hepatology·Delia D'AvolaGloria González-Aseguinolaza
May 25, 2016·Journal of Inherited Metabolic Disease·Susan E WaisbrenMark L Batshaw
May 27, 2016·World Journal of Experimental Medicine·Anja Geisler, Henry Fechner
Nov 3, 2016·Current Opinion in Pediatrics·Jamie L Fraser, Charles P Venditti
Nov 3, 2016·Expert Reviews in Molecular Medicine·Antonio FontanellasPedro Berraondo
Dec 30, 2016·Journal of the American Society of Nephrology : JASN·Dimitri TchernitchkoNicolas Pallet
Feb 17, 2017·Proceedings of the National Academy of Sciences of the United States of America·Suvasini RamaswamyInder M Verma
Aug 25, 2017·Nano Letters·Siddharth PatelGaurav Sahay

❮ Previous
Next ❯

Citations

Jul 20, 2019·Human Gene Therapy·Louisa JauzeGiuseppe Ronzitti
Feb 26, 2020·Nanomaterials·Itziar Gómez-AguadoAna Del Pozo-Rodríguez
Oct 2, 2019·BMJ Case Reports·Carlos Dias SilvaTeresa Vaio
Nov 27, 2019·Cancers·Kenya KamimuraShuji Terai
Jun 11, 2019·Human Gene Therapy·Paolo G V Martini, Lin T Guey
Jul 9, 2020·Science Advances·Jennifer NelsonJohn L Joyal
Nov 30, 2019·Frontiers in Oncology·Xiangjun TangQianxue Chen
Jan 3, 2020·British Journal of Cancer·Aldo S BaderMartin Bushell
Nov 4, 2020·Intractable & Rare Diseases Research·Lanlan ZhaoSongyun Zhang
Dec 6, 2020·Nature Reviews. Drug Discovery·Michael J MitchellRobert Langer
Feb 3, 2021·Journal of Personalized Medicine·Britt DelnoyMaria Estela Rubio-Gozalbo
Apr 17, 2020·Advanced Drug Delivery Reviews·Nuphar VeigaDan Peer
Aug 15, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chao WangChunquan Cai
Sep 2, 2021·Bioactive Materials·Lei WuJun Yue
Aug 29, 2021·Journal of Hepatology·Taihua YangAmar Deep Sharma
Sep 10, 2021·Expert Opinion on Drug Discovery·Claudia Augusta Di TraniPedro Berraondo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Biochemistry. Biokhimii︠a︡
O V SergeevaT S Zatsepin
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Bin LiYizhou Dong
© 2022 Meta ULC. All rights reserved